相关实验视频

Updated: Jul 6, 2025

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

循环瘤DNA和结肠直肠癌的管理

Matthew Krell¹, Brent Llera¹, Zachary J Brown¹

¹Department of Surgery, Division of Surgical Oncology, NYU Langone Health, NYU Grossman Long Island School of Medicine, Mineola, NY 11501, USA.

|January 11, 2024

概括

循环瘤DNA (ctDNA) 显示为检测结肠直肠癌 (CRC) 复发和指导治疗的生物标志物. 在传统方法不足的情况下,这种方法可能会改善患者的治疗结果.

科学领域:

在瘤学瘤学.
分子诊断学分子诊断学
生物标志物发现发现

背景情况:

结肠直肠癌 (CRC) 仍然是癌症死亡的重要原因,尽管查努力.
检测CRC复发的传统方法,包括CT扫描,内镜和CEA水平,并没有改善生存率.
需要更有效的生物标志物用于CRC的预后,复发监测和治疗指导.

研究的目的:

为提供循环瘤DNA (ctDNA) 作为结直肠癌 (CRC) 液体活检生物标记物的概述.
讨论ctDNA在提供预后信息,指导治疗和监测CRC患者复发方面的实用性.
探索主要瘤部位如何影响转移性CRC中的ctDNA检测能力.

主要方法:

文献综述和关于结直肠癌中ctDNA的当前研究的综合.
对调查ctDNA的研究进行分析,以预后,复发检测和治疗指导.
讨论影响ctDNA检测的因素,包括转移性疾病中的瘤位置.

主要成果:

目前正在研究ctDNA检测作为结直肠癌患者的宝贵工具.
ctDNA具有提供预后见解和监测治疗反应的潜力.
转移性疾病的位置可以影响ctDNA的检测能力.

结论:

ctDNA代表了一种有前途的非侵入性生物标志物,用于控制结肠直肠癌.
使用ctDNA的液体活检可以提高复发的早期检测,并个性化治疗策略.
需要进一步的研究,以充分阐明ctDNA在优化CRC患者护理中的作用.

关键词:

生物标志物生物标志物结肠直肠癌是什么意思 ctDNActDNA是什么意思液体活检活检液体活检转移转移转移转移

更多相关视频

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Isolation of Circulating Tumor Cells in an Orthotopic Mouse Model of Colorectal Cancer

Published on: July 18, 2017

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

相关概念视频

Cancer Stem Cells and Tumor Maintenance

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...